UNSPSC 51122605: Niacin/simvastatin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV350. This VA Drug Class (CV350) classifies this compound as belonging to the group ANTILIPEMIC AGENTS.

UNSPSC 51122605 Niacin/simvastatin is a Commodity code covering pharmaceutical products procured by state and local health agencies, emergency services, and health benefit programs. State and local governments use this code to source medications for emergency medical services, public health programs, and employee or beneficiary pharmacy benefits. Recent solicitations show issuing bodies acquiring medications through three distinct procurement channels: emergency services agencies (fire rescue departments) buying specific advanced life support medications in small unit quantities with tight delivery windows; state health benefit programs seeking direct-to-manufacturer contracting arrangements to optimize pharmacy supply chain management; and multistate cooperative purchasing alliances establishing framework agreements with manufacturers to supply generic pharmaceuticals and OTC products through authorized wholesalers to multiple jurisdictions.

The code shows activity across Texas, Florida, and the multistate MMCAP membership (Minnesota, Oregon, and participating states). The City of Tampa's Purchasing Department issued an IFB (Bid No. 26P00188) on April 24, 2026, for Advanced Life Support Medications for Tampa Fire Rescue in Hillsborough County, seeking four specific medication line items with a response deadline of April 8, 2026 and an estimated contract value of $40,000; the solicitation included a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount. The Texas Health and Human Services Commission issued a Request for Information (RFI No. HHS0017013) on April 3, 2026, to gather vendor capabilities regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued an RFP (S1070000015802) on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, requiring vendors to supply through three authorized wholesalers with pricing and product information evaluated at 75 percent weight and administrative compliance at 25 percent.